CERB is an internationally renowned Contract Research Organisation with a record of success as Partner of the Pharmaceutical Industry and Biotech Companies in the area of new drug R & D during the past 37 years.

 Highly specialised in preclinical pharmacology (in vivo/ex vivo) more than 100 models and methods are established for the assessment of efficacy and safety of new drug candidates. In regulatory toxicology we offer the whole range of studies, in different species up to a duration of 1 year. As part of our core business we provide entire Safety Packages to Support Phase I Clinical Trials. Investment in outstanding scientific and technical manpower, high-tech equipment and facilities are crucial cornerstones of our sound and organic growth. The quality and reliability of our performance is reflected by the many ongoing and long-lasting collaborations we maintain with leading international Pharmaceutical  and Biotech Companies.

Our activity consists in : recherche biologique, pharmacologie, toxicologie, phytosanitaire, médicament, recherche préclinique, biologic research, pharmacology, toxocology, medicines, preclinical research, centre de recherches biologique, biologic research center.